1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Japan AI in Drug Discovery Market
3.5. IGR-Growth Matrix Analysis
3.6. Value Chain Analysis of Japan AI in Drug Discovery Market
3.7. Competitive Landscape in Japan AI in Drug Discovery Market
4. Japan AI in Drug Discovery Market by Offering
4.1. Software
4.2. Services
5. Japan AI in Drug Discovery Market by Technology
5.1. Machine Learning
5.2. Natural Language Processing (NLP)
5.3. Computer Vision
5.4. Others
6. Japan AI in Drug Discovery Market by Application
6.1. Target Identification
6.2. Molecule Screening
6.3. Drug Design and Drug Optimization
6.4. Preclinical and Clinical Testing
6.5. Others
7. Japan AI in Drug Discovery Market by Therapeutic Area
7.1. Oncology
7.2. Neurodegenerative Diseases
7.3. Infectious Disease
7.4. Others
8. Japan AI in Drug Discovery Market by End User
8.1. Pharmaceutical & Biotechnology Companies
8.2. Contract Research Organizations
8.3. Academic & Government Research Institutes
9. Company Profiles
9.1. Company 1
9.2. Company 2
9.3. Company 3
9.4. Company 4
9.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Japan AI in Drug Discovery Market
3.5. IGR-Growth Matrix Analysis
3.6. Value Chain Analysis of Japan AI in Drug Discovery Market
3.7. Competitive Landscape in Japan AI in Drug Discovery Market
4. Japan AI in Drug Discovery Market by Offering
4.1. Software
4.2. Services
5. Japan AI in Drug Discovery Market by Technology
5.1. Machine Learning
5.2. Natural Language Processing (NLP)
5.3. Computer Vision
5.4. Others
6. Japan AI in Drug Discovery Market by Application
6.1. Target Identification
6.2. Molecule Screening
6.3. Drug Design and Drug Optimization
6.4. Preclinical and Clinical Testing
6.5. Others
7. Japan AI in Drug Discovery Market by Therapeutic Area
7.1. Oncology
7.2. Neurodegenerative Diseases
7.3. Infectious Disease
7.4. Others
8. Japan AI in Drug Discovery Market by End User
8.1. Pharmaceutical & Biotechnology Companies
8.2. Contract Research Organizations
8.3. Academic & Government Research Institutes
9. Company Profiles
9.1. Company 1
9.2. Company 2
9.3. Company 3
9.4. Company 4
9.5. Company 5